BEHÇET'S SYNDROME (BS)
Clinical trials for BEHÇET'S SYNDROME (BS) explained in plain language.
Never miss a new study
Get alerted when new BEHÇET'S SYNDROME (BS) trials appear
Sign up with your email to follow new studies for BEHÇET'S SYNDROME (BS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug targets immune attack in six diseases
Disease control Recruiting nowThis early-stage trial tests a new drug called RAY121 in 144 adults with one of six immune diseases: antiphospholipid syndrome, bullous pemphigoid, Behçet's syndrome, dermatomyositis, immune-mediated necrotizing myopathy, or immune thrombocytopenia. The drug blocks a part of the …
Matched conditions: BEHÇET'S SYNDROME (BS)
Phase: PHASE1 • Sponsor: Chugai Pharmaceutical • Aim: Disease control
Last updated May 26, 2026 06:48 UTC
-
New hope for Behçet's patients: biosimilar drug under study
Disease control Recruiting nowThis study looks at how well a biosimilar of ustekinumab works for people with Behçet's syndrome who have painful mouth and genital ulcers that didn't get better with standard treatments. About 208 adults will be observed for 52 weeks to see if the drug controls their symptoms wi…
Matched conditions: BEHÇET'S SYNDROME (BS)
Sponsor: Groupe français d'étude des Maladies Inflammatoires de loeil • Aim: Disease control
Last updated May 22, 2026 13:50 UTC